Advertisement
I-Mab

I-Mab (IMAB) Stock Overview

Explore I-Mab’s financial performance, market position, analyst ratings, and future outlook.

IMABNASDAQ
HealthcareBiotechnology
$2.88
$0.02(0.69%)
U.S. Market opens in 3h 45m
Advertisement

I-Mab (IMAB)

Meyka AI Score

Z

Key Financials

Market Cap542M
P/E Ratio-96.38
EPS (TTM)$-0.51
ROE-0.01%
Fundamental Analysis

AI Price Forecasts

1 Month$4.40
3 Months$6.45
1 Year Target$0.00

IMAB Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of I-Mab (IMAB) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -96.38 and a market capitalization of 542M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
-56.10%
Year-to-Date (YTD) Change
N/A
1-Year Change
242.32%
3-Year Change
-20.22%
5-Year Change
-94.95%
All-Time (Max) Change
-76.96%

Contact Information

240 745 6330
New Bund Center, Rockville, NaN, 200124

Company Facts

320 Employees
IPO DateJan 17, 2020
CountryUS

Frequently Asked Questions